Advances in Assisted Reproductive Technologies 1990
DOI: 10.1007/978-1-4613-0645-0_2
|View full text |Cite
|
Sign up to set email alerts
|

Limitations in the Use of Combined Gonadotropin Releasing Hormone Analog and Human Menopausal Gonadotropin for In Vitro Fertilization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

1993
1993
2005
2005

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 17 publications
0
4
0
Order By: Relevance
“…Patients diagnosed as having a poor response often require greater doses of gonadotrophins but ultimately have fewer oocytes and with poor quality (2). Various ovulation induction regimens have been used to improve the success rate in those particularly difficult cases (3)(4)(5)(6)(7). Among these protocols, ovarian stimulation combined with gonadotrophin releasing hormone (GnRH) agonist is associated with in-1 IVF Unit -Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel-Hashomer, Israel.…”
Section: Introductionmentioning
confidence: 98%
See 1 more Smart Citation
“…Patients diagnosed as having a poor response often require greater doses of gonadotrophins but ultimately have fewer oocytes and with poor quality (2). Various ovulation induction regimens have been used to improve the success rate in those particularly difficult cases (3)(4)(5)(6)(7). Among these protocols, ovarian stimulation combined with gonadotrophin releasing hormone (GnRH) agonist is associated with in-1 IVF Unit -Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel-Hashomer, Israel.…”
Section: Introductionmentioning
confidence: 98%
“…3 To whom correspondence should be addressed; e-mail: shaieliz@ netvision.net.il. creased doses of gonadotrophin (4,5). Recent studies pointed out the efficacy of GnRH antagonists in poor responders (8)(9)(10).…”
Section: Introductionmentioning
confidence: 98%
“…The introduction of stimulation protocols containing GnRH agonists (GnRH-a) in the late 1980s provided new opportunities to stimulate patients who previously had limited responses to gonadotropins. [39][40] Initial reports indicated that some low responders stimulated better following luteal phase administration of a GnRH-a. [39][40][41] Subsequent clinical experience has provided disappointing results.…”
Section: Cnrh-agonist Down Regulationmentioning
confidence: 99%
“…[39][40] Initial reports indicated that some low responders stimulated better following luteal phase administration of a GnRH-a. [39][40][41] Subsequent clinical experience has provided disappointing results. In fact, many patients who are low responders may be completely refractory to stimulation after being down regulated with a GnRH-a.…”
Section: Cnrh-agonist Down Regulationmentioning
confidence: 99%